As of 2026-05-30, the EV/EBITDA ratio of Provention Bio Inc (PRVB) is -18.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRVB's latest enterprise value is 2,347.06 mil USD. PRVB's TTM EBITDA according to its financial statements is -126.31 mil USD. Dividing these 2 quantities gives us the above PRVB EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.4x - 12.9x | 11.4x |
| Forward P/E multiples | 11.4x - 12.7x | 12.6x |
| Fair Price | (14.92) - (16.71) | (15.74) |
| Upside | -159.7% - -166.9% | -163.0% |
| Date | EV/EBITDA |